This article is missing information about biosynthesis pathway.(January 2022) |
Clinical data | |
---|---|
Trade names | Natacyn, others |
AHFS/Drugs.com | Monograph |
Routes of administration | Eye drops[1] |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | E235 (preservatives) |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.028.803 |
Chemical and physical data | |
Formula | C33H47NO13 |
Molar mass | 665.733 g·mol−1 |
3D model (JSmol) | |
Density | 1.35 g/ml g/cm3 |
Melting point | Darkens at ±200 °C with vigorous decomposition at 280-300 °C |
Solubility in water | 0.39 mg/ml |
| |
|
Natamycin, also known as pimaricin, is an antifungal medication used to treat fungal infections around the eye.[1][2] This includes infections of the eyelids, conjunctiva, and cornea.[1] It is used as eyedrops.[1] Natamycin is also used in the food industry as a preservative.[2]
Allergic reactions may occur.[1] It is unclear if medical use during pregnancy or breastfeeding is safe.[1] It is in the macrolide and polyene families of medications.[1] It results in fungal death by altering the cell membrane.[1]
Natamycin was discovered in 1955 and approved for medical use in the United States in 1978.[1][2] It is on the World Health Organization's List of Essential Medicines.[3] It is produced by fermentation of certain types of the bacterium Streptomyces.[1][4]